688266.SS
Suzhou Zelgen Biopharmaceuticals Co., Ltd.
ShanghaiCNYEQUITY
Healthcare
DELAYED
Last price
128.71
▼ 9.63 (6.96%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
133.21
Prev close
138.34
Day high
135.46
Day low
125.54
Volume
8.74M
Market cap
$34.07B
P/E (TTM)
61.58
52W range
75.10 – 160.00
Day trading desk
Gap from prior close
-3.71%
Prior close 138.34
VWAP
129.66
-0.74% from price
Relative volume
1.08×
Normal
Session range
7.75%
125.61 – 135.35
Position in range
32%
Mid range
ATR (14D)
8.40
6.53% of price
Prior day high
143.68
PDH
Prior day low
122.90
PDL
Bid / ask spread
—
Quote not published
Session volume
8.10M
Avg 7.50M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+6.90%
+8.3%
1M
-11.25%
-15.0%
3M
+30.02%
+26.9%
6M
+32.96%
+21.9%
YTD
+38.85%
+26.6%
1Y
+17.26%
-2.7%
3Y
+167.64%
+93.5%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 688266.SS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
78.37M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Apr 16, 26 | Sheng (Ze Lin) Chairman of the Board |
SELL | 273.91K | $4.08M | Direct |
| Apr 16, 26 | Sheng (Ze Lin) Chairman of the Board |
SELL | 273.91K | $4.08M | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Sheng (Ze Lin) |
Chairman of the Board | 49.64M | Sale |
Fundamentals
Market cap$34.07B
Enterprise value$32.41B
Revenue (TTM)$1.64B
Gross profit$1.53B
EBITDA$496.32M
Net income$549.87M
EPS (TTM)$2.09
Free cash flow$191.14M
Total cash$2.47B
Total debt$812.94M
Book value / share$6.50
Shares outstanding264.71M
Float167.35M
Short % of float—
Dividend yield—
Beta (5Y)-0.11
Valuation & profitability ratios
Trailing P/E61.58
Forward P/E-1,838.71
PEG ratio—
Price / sales—
Price / book19.80
EV / revenue19.76
EV / EBITDA65.31
Gross margin93.31%
Operating margin-6.53%
Profit margin33.52%
Return on equity38.00%
Return on assets8.80%
Debt / equity47.25
Current ratio2.50
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $810.48M | $532.95M | $386.44M | $302.31M | +52.1% |
| Operating revenue | $810.48M | $532.95M | $386.44M | $302.31M | +52.1% |
| Cost of revenue | $77.63M | $36.99M | $29.21M | $26.16M | +109.9% |
| Gross profit | $732.85M | $495.96M | $357.23M | $276.14M | +47.8% |
| Research & development | $429.91M | $388.00M | $496.33M | $497.73M | +10.8% |
| Selling, general & admin | $337.73M | $149.60M | $100.41M | $156.72M | +125.8% |
| Total operating expense | $928.23M | $683.28M | $682.95M | $779.97M | +35.8% |
| Operating income | -$195.38M | -$187.32M | -$325.72M | -$503.82M | -4.3% |
| Net interest income | $30.54M | $29.19M | $14.90M | $13.80M | +4.6% |
| Pre-tax income | -$168.65M | -$155.05M | -$299.08M | -$487.95M | -8.8% |
| Tax provision | -$3.53M | -$4.75M | -$3.95M | -$2.45M | +25.7% |
| Net income | -$162.95M | -$137.83M | -$278.58M | -$457.33M | -18.2% |
| Net income to common | -$162.95M | -$137.83M | -$278.58M | -$457.33M | -18.2% |
| Basic EPS | -0.62 | -0.52 | -1.09 | -1.91 | -19.2% |
| Diluted EPS | -0.62 | -0.52 | -1.09 | -1.91 | -19.2% |
| EBIT | -$144.45M | -$126.15M | -$276.53M | -$475.92M | -14.5% |
| EBITDA | -$94.48M | -$70.56M | -$221.70M | -$409.55M | -33.9% |
| Basic shares | 262.82M | 265.06M | 255.58M | 239.44M | -0.8% |
| Diluted shares | 262.82M | 265.06M | 255.58M | 239.44M | -0.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $2.03B | $2.15B | $2.11B | $797.05M | -5.7% |
| Cash & short-term investments | $2.03B | $2.19B | $2.25B | $1.05B | -7.4% |
| Accounts receivable | $151.22M | $143.30M | $101.14M | $88.99M | +5.5% |
| Inventory | $173.27M | $182.86M | $110.85M | $98.98M | -5.2% |
| Total current assets | $2.44B | $2.58B | $2.52B | $1.29B | -5.2% |
| Property, plant & equipment | $485.89M | $363.43M | $271.21M | $247.09M | +33.7% |
| Goodwill & intangibles | $30.59M | $50.01M | $69.27M | $91.03M | -38.8% |
| Total assets | $2.97B | $3.00B | $2.89B | $1.67B | -1.2% |
| Total current liabilities | $1.43B | $1.37B | $1.14B | $729.19M | +4.0% |
| Current debt | $989.05M | $951.86M | $795.16M | $390.79M | +3.9% |
| Long-term debt | $84.00M | $44.35M | — | $50.09M | +89.4% |
| Total debt | $1.13B | $1.04B | $888.35M | $547.80M | +9.0% |
| Total liabilities | $1.89B | $1.75B | $1.24B | $880.82M | +7.8% |
| Retained earnings | -$2.28B | -$2.12B | -$1.98B | -$1.70B | -7.7% |
| Shareholder equity | $1.08B | $1.25B | $1.63B | $759.12M | -13.8% |
| Working capital | $1.02B | $1.20B | $1.39B | $562.57M | -15.6% |
| Net tangible assets | $1.05B | $1.20B | $1.56B | $668.09M | -12.8% |
| Shares issued | 264.71M | 264.71M | 264.71M | 240.00M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$165.13M | -$150.30M | -$295.13M | -$485.51M | -9.9% |
| Depreciation & amortisation | $49.98M | $55.60M | $54.83M | $66.37M | -10.1% |
| Change in working capital | $104.75M | $151.21M | $24.53M | -$225.28K | -30.7% |
| Operating cash flow | -$28.78M | $38.20M | -$232.75M | -$370.34M | -175.3% |
| Capital expenditure | -$181.47M | -$95.69M | -$62.60M | -$88.62M | -89.6% |
| Investing cash flow | -$55.63M | -$1.85B | $64.84M | -$264.06M | +97.0% |
| Dividends paid | -$26.09M | -$24.56M | -$21.17M | -$11.22M | -6.2% |
| Financing cash flow | -$7.50M | -$51.32M | $1.51B | $282.79M | +85.4% |
| Free cash flow | -$210.25M | -$57.49M | -$295.35M | -$458.97M | -265.7% |
| End cash position | $124.66M | $217.27M | $2.08B | $736.11M | -42.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $299.99M | $905.39M | $217.04M | $208.01M | $167.64M | -66.9% |
| Operating revenue | $299.99M | $905.39M | $217.04M | $208.01M | $167.64M | -66.9% |
| Cost of revenue | $37.55M | $27.04M | $20.69M | $19.35M | $19.47M | +38.9% |
| Gross profit | $262.44M | $878.35M | $196.36M | $188.66M | $148.17M | -70.1% |
| Research & development | $107.25M | $92.28M | $127.13M | $94.27M | $102.24M | +16.2% |
| Selling, general & admin | $53.17M | $151.23M | -$40.55M | $49.49M | $109.14M | -64.8% |
| Total operating expense | $254.89M | $245.85M | $274.28M | $234.61M | $188.69M | +3.7% |
| Operating income | $7.55M | $632.51M | -$77.92M | -$45.95M | -$40.51M | -98.8% |
| Net interest income | $15.25M | $1.12M | $5.64M | $7.37M | $6.70M | +1,263.9% |
| Pre-tax income | $6.88M | $631.77M | -$70.34M | -$47.10M | -$30.32M | -98.9% |
| Tax provision | -$522.57K | -$841.97K | -$805.16K | -$841.38K | -$1.00M | +37.9% |
| Net income | $7.40M | $632.61M | -$69.53M | -$44.54M | -$28.26M | -98.8% |
| Net income to common | $7.40M | $632.61M | -$69.53M | -$44.54M | -$28.26M | -98.8% |
| Basic EPS | — | 2.39 | — | — | -0.11 | — |
| Diluted EPS | — | 2.39 | — | — | -0.11 | — |
| EBIT | $12.18M | $637.77M | -$63.36M | -$40.43M | -$23.11M | -98.1% |
| EBITDA | $12.18M | $637.77M | -$63.36M | -$40.43M | -$23.11M | -98.1% |
| Basic shares | — | 264.69M | — | — | 256.93M | — |
| Diluted shares | — | 264.69M | — | — | 256.93M | — |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.09B | $2.22B | $2.03B | $2.12B | $2.10B | -5.6% |
| Cash & short-term investments | $2.47B | $2.68B | $2.03B | $2.15B | $2.14B | -8.0% |
| Accounts receivable | $204.28M | $184.93M | $151.22M | $175.40M | $137.42M | +10.5% |
| Inventory | $192.87M | $178.26M | $173.27M | $164.22M | $167.49M | +8.2% |
| Total current assets | $2.96B | $3.16B | $2.44B | $2.55B | $2.50B | -6.2% |
| Property, plant & equipment | $522.62M | $495.20M | $485.89M | $366.13M | $351.61M | +5.5% |
| Goodwill & intangibles | $24.46M | $26.92M | $30.59M | $40.18M | $45.10M | -9.2% |
| Total assets | $3.53B | $3.69B | $2.97B | $3.00B | $2.92B | -4.4% |
| Total current liabilities | $1.19B | $1.34B | $1.43B | $1.34B | $1.33B | -11.5% |
| Current debt | $674.86M | $842.99M | $989.05M | $976.36M | $881.53M | -19.9% |
| Long-term debt | $83.50M | $84.00M | $84.00M | $125.70M | $59.81M | -0.6% |
| Total debt | $812.94M | $985.61M | $1.13B | $1.14B | $1.00B | -17.5% |
| Total liabilities | $1.81B | $1.98B | $1.89B | $1.82B | $1.69B | -8.6% |
| Retained earnings | -$1.64B | -$1.65B | -$2.28B | -$2.19B | -$2.15B | +0.4% |
| Shareholder equity | $1.72B | $1.71B | $1.08B | $1.18B | $1.23B | +0.4% |
| Working capital | $1.78B | $1.82B | $1.02B | $1.21B | $1.17B | -2.4% |
| Net tangible assets | $1.70B | $1.69B | $1.05B | $1.14B | $1.18B | +0.6% |
| Shares issued | 264.71M | 264.71M | 264.71M | 264.71M | 264.71M | 0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Capital expenditure | -$15.62M | -$33.80M | -$48.97M | -$45.91M | -$33.81M | +53.8% |
| Investing cash flow | $1.02B | -$605.02M | $10.92M | -$35.71M | -$26.63M | +268.2% |
| Dividends paid | -$5.15M | -$5.79M | -$6.63M | -$6.42M | -$6.30M | +11.2% |
| Financing cash flow | -$179.65M | -$157.98M | -$6.82M | $57.71M | -$31.80M | -13.7% |
| Free cash flow | -$44.52M | $803.61M | -$61.02M | -$56.67M | -$40.06M | -105.5% |
| End cash position | $1.00B | $194.57M | $124.66M | $163.36M | $152.58M | +415.3% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | 1.90 | 4 | $1.81B | +123.5% |
| Next year | 1.79 | 4 | $2.16B | +19.5% |
Analyst targets & ownership
Mean target$139.05
High target$161.08
Low target$121.07
Implied upside8.03%
Analyst count3
ConsensusSTRONG BUY
Strong buy / Buy1 / 3
Hold0
Sell / Strong sell0 / 0
Held by insiders29.61%
Held by institutions28.55%
Institutions holding112
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
123.23
+4.44% from price
SMA 20
121.64
+5.81% from price
SMA 50
121.85
+5.63% from price
SMA 100
110.55
+16.42% from price
SMA 200
102.73
+25.29% from price
EMA 12
124.38
+3.48% from price
EMA 26
123.68
+4.07% from price
EMA 50
120.37
+6.93% from price
RSI (14)
54.0
Neutral
MACD (12,26,9)
0.71
Hist 1.24
ATR (14)
8.40
6.53% of price
Realised vol 30D
86.3%
Annualised
Bollinger upper
138.90
20, 2σ
Bollinger lower
104.39
20, 2σ
50 / 200 cross
Golden
121.85 vs 102.73
Trend bias
Above 200
+25.29%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.31
Less volatile than market
Correlation to SPY
-0.06
Largely independent
Realised vol 30D
86.3%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-37.3%
Peak to trough
Max drawdown 5Y
-65.1%
Peak to trough
ATR 14
8.40
6.53% of price
Beta (reported)
-0.11
5Y monthly, from filing
Headlines
The “No-Contest Clause”: One Sentence That Makes Challenging Your Will Cost a Child Everything You Left Them.
24/7 Wall St. · 8m ago
Ukraine backers gather as war escalates, air defence runs low
AFP · 10m ago
Dow Jones Futures: Tariffs In Focus; Nvidia, Warsh Ahead
Investor's Business Daily · 15m ago
Nissan scrapped a bank it couldn't afford to build
TheStreet · 15m ago
Micron, Sandisk, and SK Hynix: History Says This About the Memory Trio's Rally
Motley Fool · 17m ago
Disney Adds Formula E to Disney+: Can Live Sports Strengthen its Streaming Business?
Insider Monkey · 18m ago
4-H rabbit show proves dedication of members
The Lima News, Ohio · 21m ago
Benz Announces A$150m Placement to Accelerate Delivery of Glenburgh Maiden Resource
TMX Newsfile · 22m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.